Check-Cap Ltd. completed the closing of its business combination with MBody AI Corp. on August 26, 2026, and finalized an underwritten public offering of 1,538,462 ordinary shares at $6.50 per share on August 27, 2026. The transaction generated approximately $10.0 million in gross proceeds before deducting underwriting discounts and expenses. The company granted the underwriter a 30-day option to purchase up to an additional 230,769 shares at the same price. Following these transactions, the issuer has approximately 15,293,552 ordinary shares issued and outstanding, with roughly 81% held by former MBody AI shareholders subject to lock-up restrictions. The company intends to use net proceeds for robot deployments, working capital, and general corporate purposes. Check-Cap Ltd., which will operate under the name MBody AI Ltd., operates in the embodied artificial intelligence industry as an enterprise robotics platform that deploys autonomous robot workforces.

Check-Cap Ltd completed a merger with MBody AI Corp on August 26, 2026. Former MBody AI shareholders received approximately 12,379,581 Ordinary Shares, representing roughly 90% of the post-merger equity, in exchange for their shares at a conversion ratio of 0.07971678051816 per share. No cash was paid to MBody AI shareholders. Concurrently, Check-Cap terminated its prior business combination agreement with Apollo Technology Capital Corporation and exchanged $16.3 million in outstanding loans for a 7.5% equity stake in Apollo, which was then cancelled. The company's stock symbol changed to 'MBAI' on Nasdaq. Executive leadership shifted as John Fowler replaced David Lontini as CEO and Tim Hayden replaced Alan Lewis as CFO. A new board of seven directors was appointed, with four designated as independent. Check-Cap Ltd operates in the medical technology sector, specializing in non-invasive gastrointestinal diagnostics.

Check-Cap Ltd filed a Form 6-K to incorporate by reference into its S-8 registration statements. The filing confirms that shareholders approved the previously announced Agreement and Plan of Merger with MBody AI Corp at an annual general meeting on November 14, 2025. It details the Board's determination that directors Ghaleb El Masri, Anurag Sharma, Kai Sorensen, and Scott Walters are independent under Nasdaq rules. The filing outlines expected committee compositions effective upon the merger closing: Audit (Sorensen, El Masri, Walters), Compensation (Sharma, El Masri, Walters), and Nominating (Sharma, Sorensen, Walters). These appointments are contingent on the transaction's completion. Check-Cap Ltd operates in the medical technology industry, developing non-invasive diagnostic devices.

Check-Cap Ltd. announced a 1-for-7 reverse share split of its ordinary shares, effective August 12, 2026. The Board approved the action on July 31, 2026, following shareholder approval at the November 14, 2025 Annual General Meeting. This consolidation reduces issued and outstanding shares from approximately 9,463,062 to roughly 1,351,866, with fractional shares rounded up to the nearest whole share. Check-Cap Ltd. is a technology company executing a strategic transformation through its merger with MBody AI to become a leader in embodied artificial intelligence for robotic systems.

Check-Cap Ltd. filed a Form 6-K incorporating by reference a press release dated August 6, 2026, regarding MBody AI Corp., the target of its proposed business combination. The filing announces that MBody AI has secured exclusive U.S. distribution rights for outdoor cleaning robots in gaming and hospitality sectors across six states: Nevada, Arizona, New Jersey, Pennsylvania, California, and Connecticut. This expansion allows MBody AI to deploy autonomous solutions via its Orchestrator platform in outdoor environments, building on existing indoor deployments with major operators. The press release also reiterates that the merger between Check-Cap and MBody AI is targeted to close in the third quarter of 2026, pending SEC effectiveness of the Form F-1 registration statement and Nasdaq listing approval. Check-Cap Ltd. operates as a technology company executing a strategic transformation through its shareholder-approved merger with MBody AI Corp., aiming to become a provider of embodied artificial intelligence for robotic systems in hospitality, gaming, and commercial real estate.

Check-Cap Ltd. updated the expected closing timeline for its proposed business combination with MBody AI Corp., now projecting completion in the third quarter of 2026, specifically within eight weeks from August 5, 2026. This updates the previous expectation of a second-half 2026 close. The company publicly filed its registration statement on Form F-1 with the SEC on July 24, 2026, and has responded to all staff comments. Shareholder approval for the merger was obtained from both entities. Completion remains subject to final Nasdaq listing approval and satisfaction of customary closing conditions. Check-Cap Ltd. is a technology company executing a strategic transformation through its shareholder-approved merger with MBody AI Corp., which will result in a publicly traded provider of embodied artificial intelligence delivering enterprise-grade AI orchestration for robotic systems across hospitality, gaming, and commercial real estate operations.